Epilepsy Market Research Reports & Industry Analysis
Epilepsy Industry Research & Market Reports
-
Global Brain Imaging Devices Market Size study, by Product (Devices, Accessories) by Application (Stroke, Brain Tumor, Traumatic brain injury (TBI), Epilepsy, Sleep Apnea, Headache, Structural anomalies, Other Applications) by Modality (Fixed, Portable, W
... Use (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers, Other End-users) and Regional Forecasts 2022-2032 Global Brain Imaging Devices Market is valued approximately USD 5.26 billion in 2023 and is anticipated to grow with a growth ... Read More
-
Deep Brain Stimulation Devices
... reach US$2.9 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Dual-Channel Deep Brain Stimulation Devices, one of the segments analyzed in the report, is expected to record a 8.0% ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
Global Deep Brain Stimulation Market: Analysis By Product (Dual Channel and Single Channel), By Application (Parkinson’s Disease, Essential Tremor, Dystonia, Epilepsy and Others), By End Use (Hospitals, Neurology Clinics, Ambulatory Surgical Clinics and Research Centers), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2023 Base Year 2023 Forecast Period 2024-2029 Page Count 153 Units Referenced US ... Read More
-
Global Anti Epilepsy Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 4130.1 million by 2030 with a CAGR of 2.0% during review period. Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, ... Read More
-
Global Epilepsy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 5939.7 million by 2030 with a CAGR of 2.8% during review period. Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory ... Read More
-
Global Dravet Syndrome Treatment Market 2024-2028
... dravet syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Electroceutical Bioelectric Medicine Market 2024-2028
... electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Drug Resistant Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Drug Resistant Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Drug Resistant Epilepsy market report provides current ... Read More
-
KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE), historical and forecasted epidemiology as well as the KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Partial Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Partial Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Partial Epilepsy market report provides current treatment practices, emerging drugs, Partial ... Read More
-
Global Epilepsy Drugs Market Size study & Forecast, by Drugs (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics), by Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others) and Regional Analysis, 2023-2030
... is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2023-2030. Epilepsy is a neurological disorder characterized by ... Read More
-
Refractory Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Refractory Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Refractory Epilepsy market report provides current treatment practices, emerging drugs, Refractory ... Read More
-
Dravet Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Dravet Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Dravet Syndrome market report provides current treatment practices, emerging drugs, Dravet ... Read More
-
Chronic Focal Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Chronic Focal Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Focal Epilepsy market report provides current ... Read More
-
Global Epilepsy Therapeutics Market Size study & Forecast, by Product Type (Antiepileptic Drugs (AEDs), Devices, Surgical Instruments) by End User (Hospitals, Clinics, Home care settings) and Regional Analysis, 2023-2030
... approximately USD 0.85 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.52%% over the forecast period 2023-2030. Epilepsy is a chronic noncommunicable disease of the brain that ... Read More
-
North America & Europe Epilepsy Market Research Report Information Forecast to 2032 Based on Condition (Generalized Epilepsy and Focal Epilepsy), By diagnosis & treatment, By End User (hospitals & clinics, diagnostic centers, and others), By Region (US, Canada, Europe).
... (US, Canada, Europe) It is projected that the epilepsy market in North America and Europe would increase at a strong rate throughout the study period, with a compound annual growth rate of 8.18%. Recurrent seizures ... Read More
-
Epilepsy - Global Clinical Trials Review, 2024
... the clinical trials on Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Neurodiagnostics Market, By Product Type (Electroencephalogram (EEG) Systems, Magnetic Resonance Imaging Systems, Ultrasound Imaging Systems, Computed Tomography Scanner, Reagents & Consumables, and Others), By Therapeutic Area (Neurodegenerative Diseases, Sleep Disorders, Stroke, Epilepsy, and Others), By End User (Hospitals, Diagnostic Centers, Ambulatory Care Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... End User (Hospitals, Diagnostic Centers, Ambulatory Care Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Neurodiagnostics refers to the diagnosis of neurological disorders through various imaging and ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Electroceuticals Market Size, Trends, Analysis, and Outlook By Product (Implantable Cardioverter Defibrillators, Cochlear Implants, Neuromodulators, Retinal Implants), By Type (Implantable Electroceutical Devices, Noninvasive Electroceutical Devices), By Application (Arrhythmia, Depression, Parkinson’s Disease, Tremor, Epilepsy, Sensorineural Hearing Loss, Others), By End-User (Hospitals, Clinics, ASCs, Others), by Country, Segment, and Companies, 2024-2032
... Loss, Others), By End-User (Hospitals, Clinics, ASCs, Others), by Country, Segment, and Companies, 2024-2032 The global Electroceuticals market size is poised to register 7.8% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Brain Monitoring Market Size, Trends, Analysis, and Outlook By Device (Magnetic Resonance Imaging (MRI) Scanners, Computerized Tomography (CT) Scanners, Electroencephalograph (EEG) Devices, Positron Emission Tomography (PET) Scanners, Sleep Monitoring Devices, Cerebral Oximeters, Electromyography (EMG) Devices, Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure (Invasive Procedures, Non-invasive Procedures), By Modality (Fixed, Portable, Wearable), By Indication (Traumatic Brain Injury (TBI), Stroke, Dementia, Headache Disorders, Sleep Disorders, Parkinson’s Disease, Epilepsy, Huntington's Disease, Others), By End-User (Hospitals, Neurology Centers, Ambulatory Surgery Centers (ASCs), Diagnostic Centers, Others), by Country, Segment, and Companies, 2024-2032
... Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure (Invasive Procedures, Non-invasive Procedures), By Modality (Fixed, ... Read More
-
Anti-Epileptic Drugs/Epilepsy - Pipeline Insight, 2024
... picture of the Anti-Epileptic Drugs/Epilepsy pipeline landscape is provided, which includes the disease overview and Anti-Epileptic Drugs/Epilepsy treatment guidelines. The assessment part of the report embraces in-depth Anti-Epileptic Drugs/Epilepsy commercial assessment and clinical assessment of ... Read More
-
India Medical Cannabis Market Assessment, By Species [Indica, Sativa, Hybrid], By Derivatives [Cannabidiol, Tetrahydrocannabinol, Others], By Route of Administration [Oral, Topical, Others], By Form [Oils, Capsules, Tinctures], By Therapeutic Application [Cancer, Migraine, Epilepsy, Anxiety and Depression, Others], By End-user [Pharmaceutical Industry, Research and Development Centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Depression, Others], By End-user [Pharmaceutical Industry, Research and Development Centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F India medical cannabis market is projected to witness a CAGR of 15.05% during the forecast period FY2024-FY2031, growing ... Read More
-
Central Nervous System Disorders Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Depression Drugs, Multiple Sclerosis Drugs, Schizophrenia Drugs, Bipolar Disorder Therapeutics, Epilepsy Drugs, Others), By Drug Class (Analgesics, Antidepressant, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Others), by Region, Country, Segment, and Companies, 2024-2030 The global Central Nervous System Disorders Therapeutics market size is poised to register 6.94% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
Research Assistance
